VIP is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
VIP results typically emerge over a ongoing continuous therapy research cycle. Early changes may be noticeable within the first 1-2 weeks, with more significant effects on vasodilation appearing by weeks 4-8. Results depend on dosage (50-100 mcg per spray or 200 mcg daily inhaled), consistency, and individual factors.
What Results Can You Expect From VIP?
VIP (Vasoactive Intestinal Peptide) is a Neuropeptide, vasodilator, anti-inflammatory researched for vasodilation, bronchodilation, anti-inflammatory effects, neuroprotection, lung function improvement. Results depend on dosage (50-100 mcg per spray or 200 mcg daily inhaled), administration frequency (4 times daily (nasal) or daily (inhaled)), and individual factors.
The following timeline is based on standard 50-100 mcg per spray or 200 mcg daily inhaled protocols over a ongoing continuous therapy cycle.
What Happens in Weeks 1-2 of VIP?
During the first two weeks, VIP is establishing baseline blood levels. With a half-life of 2 minutes (extremely short), steady-state concentrations are typically reached within 4-5 half-lives.
Subtle changes researchers may notice: improved vasodilation, better sleep quality (commonly reported across peptide protocols), and mild injection site reactions that typically resolve.
What Changes by Weeks 3-4?
By week 3-4, the biological pathways VIP targets are becoming measurably activated. Activates VPAC1 and VPAC2 class B G protein-coupled receptors, initiating adenylyl cyclase-cAMP cascade and CREB phosphorylation. Drives smooth muscle relaxation via calcium channel modulation, vasodi.
More noticeable effects on vasodilation, bronchodilation, anti-inflammatory effects begin to emerge. This is the phase where most researchers report the first clear evidence that the compound is working.
What Results Appear at Weeks 5-8?
Weeks 5-8 represent the peak response window for most Neuropeptide, vasodilator, anti-inflammatory compounds. Cumulative effects of consistent 4 times daily (nasal) or daily (inhaled) dosing at 50-100 mcg per spray or 200 mcg daily inhaled produce the most visible changes.
Key results during this phase typically include pronounced improvements in vasodilation, bronchodilation, anti-inflammatory effects, neuroprotection, lung function improvement. This is when before-and-after differences become most apparent.
What About Weeks 8-12 and Beyond?
For extended VIP cycles (ongoing continuous therapy), weeks 8-12 often show the most dramatic cumulative results. However, diminishing returns and receptor adaptation can occur.
Many protocols include a washout period after the cycle to restore baseline sensitivity. Combines with inhaled corticosteroids or bronchodilators for synergistic airway relaxation in asthma/COPD.
How Can You Maximize VIP Results?
Consistent dosing at 50-100 mcg per spray or 200 mcg daily inhaled 4 times daily (nasal) or daily (inhaled) is the single biggest factor. Skipping doses or inconsistent timing significantly reduces outcomes.
Proper storage (reconstituted at 2-8°C), sourcing from COA-tested vendors, and supporting protocols (nutrition, sleep, training where applicable) all contribute to results.
Combines with inhaled corticosteroids or bronchodilators for synergistic airway relaxation in asthma/COPD.
Calculate Your VIP Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for VIP.
Open Calculator →What Is the Realistic VIP Timeline?
Expect initial effects in weeks 1-2, noticeable changes by weeks 3-4, and peak results during weeks 5-8 of a ongoing continuous therapy cycle. VIP is not instant — consistent dosing and patience are required.
VIP is not fda-approved. orphan drug designation for pulmonary hypertension. fda announced plans to remove from compounding lists.
Complete Guide
VIP : Benefits, Dosage, Side Effects & Research
Related Reading
Research-Grade Sourcing
If you're going to research VIP, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is VIP?
VIP (Vasoactive Intestinal Peptide) is a Neuropeptide, vasodilator, anti-inflammatory. Endogenous 28-amino acid neuropeptide produced in gut, pancreas, brain, and neuroendocrine tissues. It is researched for vasodilation, bronchodilation, anti-inflammatory effects, neuroprotection, lung function improvement.
What is the recommended VIP dosage?
Common dosages: 50-100 mcg per spray or 200 mcg daily inhaled administered 4 times daily (nasal) or daily (inhaled) via intranasal spray or inhalation. Cycle length: ongoing continuous therapy. Half-life: 2 minutes (extremely short). Use our peptide calculator for exact reconstitution math.
What are the side effects of VIP?
Limited clinical data. Nasal irritation possible. Short half-life limits systemic toxicity. Well-tolerated in preliminary studies.
Is VIP safe?
VIP has shown a favorable safety profile in research. Not FDA-approved. Orphan drug designation for pulmonary hypertension. FDA announced plans to remove from compounding lists. All research should follow appropriate safety protocols.